Strategies for Effective Cell Line Development eBook
Approximately 70% of all recently approved biopharmaceuticals were recombinant proteins expressed from mammalian cell lines. In turn, the need for more stable, scalable, and high-titer cell lines is on the rise. With the global cell line development (CLD) market estimated to grow to more than $9.8 billion (CAGR ~12.5%), this demand shows no signs of slowing down. More and more companies and institutions are looking for ways to streamline and expedite the CLD process to meet market demand.
Download this content collection to learn:
- Key and points to consider during the CLD workflow
- The impact early, data-driven decision-making can have on later stages of development
- How to accelerate process optimization by incorporating innovative analytical techniques
Watch this webinar to learn how the iQue®3, Octet® and Ambr® 15 CC platforms, combined with Sartorius expertise, can help streamline early cell line development with an integrated solution that is data-driven at every step.